// App-Quantinova.ai

: Nivolumab Maintenance in First Complete Remission of Diffuse Large B-Cell Lymphoma

Researchers

Presenter

  • Meirav Kedmi

Principal Investigators

  • Elena Ribakovsky

  • Ohad Benjamini

  • Avichai Shimoni

  • Abraham Avigdor

Medical Centers

  • Tel-Aviv University, Sackler School of Medicine, Tel-Aviv, Israel

  • Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel

  • Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Ramat Gan, Israel

  • CHAIM SHEBA MEDICAL CENTER, Ramat Gan, Israel

  • Bar-Ilan University, The Mina and Everard Goodman Faculty of Life Sciences, Ramat Gan, Israel

Locations

  • Israel

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Diffuse large B-cell lymphoma

Biomarkers

  • N/A

Drug/Treatment

  • Nivolumab

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved